Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

Chongqing Precision Biotech Co., Ltd · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
acute-myeloid-leukemia
acute myeloid leukemia, blastic plasmacytoid dendritic cell neoplasm (bpdcn), relapse leukemia, refractory leukemia, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1030242
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.